Label-free technologies for drug discovery /

Over the past two decades the benefits of label-free biosensor analysis have begun to make an impact in the market, and systems are beginning to be used as mainstream research tools in many drug discovery laboratories. Label-Free Technologies For Drug Discovery summarises the latest and emerging dev...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Cooper, M. A. (Matthew A.), Mayr, Lorenz
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Chichester, West Sussex, U.K. : John Wiley & Sons, 2011.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 08419nam a2200733 4500
001 ocn705353428
003 OCoLC
005 20170124071917.8
006 m o d
007 cr cn|||||||||
008 110304s2011 enk ob 001 0 eng d
040 |a DG1  |b eng  |e pn  |c DG1  |d EBLCP  |d YDXCP  |d OCLCQ  |d E7B  |d CDX  |d IDEBK  |d OCLCQ  |d N$T  |d OCLCF  |d OCLCQ  |d RECBK  |d OCLCQ  |d COO  |d OCLCQ  |d DEBBG  |d GrThAP 
019 |a 742333157  |a 772397865  |a 816879069  |a 900725946  |a 927509689 
020 |a 9780470979129  |q (electronic bk.) 
020 |a 0470979127  |q (electronic bk.) 
020 |a 9780470979136  |q (electronic bk.) 
020 |a 0470979135  |q (electronic bk.) 
020 |a 9780470746837 
020 |a 0470746831 
020 |z 1283373963 
020 |z 9781283373968 
029 1 |a AU@  |b 000047226090 
029 1 |a NZ1  |b 14693816 
029 1 |a NZ1  |b 15916017 
029 1 |a DEBBG  |b BV043392812 
035 |a (OCoLC)705353428  |z (OCoLC)742333157  |z (OCoLC)772397865  |z (OCoLC)816879069  |z (OCoLC)900725946  |z (OCoLC)927509689 
037 |a 10.1002/9780470979129  |b Wiley InterScience  |n http://www3.interscience.wiley.com 
050 4 |a RM301.25  |b .L33 2011 
060 4 |a QV 744 
072 7 |a TDCW  |2 bicssc 
072 7 |a MED  |x 023000  |2 bisacsh 
072 7 |a MED  |x 058170  |2 bisacsh 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a MED  |x 072000  |2 bisacsh 
082 0 4 |a 615/.19  |2 22 
049 |a MAIN 
245 0 0 |a Label-free technologies for drug discovery /  |c editors, Matthew Cooper, Lorenz Mayr. 
264 1 |a Chichester, West Sussex, U.K. :  |b John Wiley & Sons,  |c 2011. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a Front Matter -- The Revolution of Real-Time, Label-Free Biosensor Applications / Rebecca L Rich, David G Myszka -- Design and Implementation of Vertically Emitting Distributed Feedback Lasers for Biological Sensing / Meng Lu, Steven S Choi, Chun Ge, Clark J Wagner, J Gary Eden, Brian T Cunningham -- SPR Screening of Chemical Microarrays for Fragment-Based Discovery / Thomas Neumann, Renate Sekul -- The CellKeyʼ System: A Label-Free Cell-Based Assay Platform for Early Drug Discovery Applications / Ryan P McGuinness, Debra L Gallant, Yen-Wen Chen, Trisha A Tutana, Donna L Wilson, John M Proctor, H Roger Tang -- Dynamic and Label-Free Cell-Based Assays Using the xCELLigence System / Yama A Abassi, Alexander Sieler, Manfred Watzele, Xiaobo Wang, Xiao Xu -- Selecting the Best HTS Hits to Move Forward: ITC Ligand Binding Characterization Provides Guidance / Ronan O'Brien, Richard Brown -- Incorporating Transmitted Light Modalities into High-Content Analysis Assays / Robert Graves -- Nonradioactive Rubidium Efflux Assay Technology for Screening of Ion Channels / Georg C Terstappen -- Expanding the Scope of HTMS Methods / Tom G Holt, Jun Wang, Xun Chen, Bernard K Choi, Neil S Geoghagen, Kristian K Jensen, Maxine Jonas, Qi Luo, William A LaMarr, Lorraine Malkowitz, Can C Ozbal, Yusheng Xiong, Claude Dufresne, Ming-Juan Luo -- A Novel Multiplex SPR Array for Rapid Screening and Affinity Determination of Monoclonal Antibodies: The ProteOn XPR36 Label Free System: Kinetic Screening of Monoclonal Antibodies / Vered Bronner, Oded Nahshol, Tsafrir Bravman -- Biophysics/Label-Free Assays in Hit Discovery and Verification / Johannes Ottl -- Harnessing Optical Label-Free on Microtiter Plates for Lead Finding: From Binding to Phenotypes / Julio Martin -- Use of Label-Free Detection Technologies in the Hit-to-Lead Process: Surface Optical Detection of Cellular Processes / F Stuhmeier, J Bradley, E Fairman, E Gbekor, P Hayter, S Ramsey -- Cellular Screening for 7TM Receptors Using Label-Free Detection / Jeffrey C Jerman, Jason Brown, Magalie Rocheville -- Novartis Evaluation of the ForteBio Octet RED: A Versatile Instrument for Direct Binding Experiments / Eric Martin, John Wang, Isabel Zaror, Jiamin Yu, Kelly Yan, Mike Doyle, Paul Feucht, Kevin Shoemaker, Bob Warne, Mike Chin, Blisseth Sy, Lukas Leder, Marco Meyerhofer, Charles Wartchow, Danfeng Yao -- The Pyramid₉ Approach to Fragment-Based Biophysical Screening / Glyn Williams -- Characterisation of Antibodies Against the Active Conformation of G Using the SRU-BINDʼ Label-Free Detection System / Melanie Leveridge, Chun-Wa Chung, Trevor Wattam -- SPR-Based Direct Binding Assays in Drug Discovery / Walter Huber -- Kinetic Binding Mechanisms: Their Contribution to an Optimal Therapeutic Index / David C Swinney -- ITC: More Than Just Binding Affinities / Ernesto Freire -- Index. 
505 0 |a The revolution of real-time, label-free biosensor applications / Rebecca L. Rich and David G. Myszka -- Design and implementation of vertically emitting distributed feedback lasers for biological sensing / Meng Lu [and others] -- SPR screening of chemical microarrays for fragment based discovery / Thomas Neumann and Renate Sekul -- The cellkey system : a label-free cell-based assay platform for early drug discovery applications / Ryan P. McGuinness [and others] -- Dynamic and label-free cell-based assays using the xcelligence system / Yama A. Abassi [and others] -- Selecting the best HTS hits to move forward : ITC ligand binding characterization provides guidance / Ronan O'Brien & Richard Brown -- Incorporating transmitted light modalities into high-content analysis assays / Robert Graves -- Nonradioactive rubidium efflux assay technology for screening of ion channels / Georg C. Terstappen -- Expanding the scope of HTMS methods / Tom G. Holt [and others] -- A novel multiplex SPR array for rapid screening and affinity determination of monoclonal antibodies : the proteon XPR36 label free system : kinetic screening of monoclonal antibodies / Vered Bronner, Oded Nahshol, and Tsafrir Bravman -- Biophysics/label-free assays in hit discovery and verification / Johannes Ottl -- Harnessing optical label-free on microtiter plates for lead finding from binding to phenotypes / Julio Martin -- Use of label-free detection technologies in the hit-to-lead process: surface optical detection of cellular processes / F. Stuhmeier [and others] -- Cellular screening for 7TMS using label-free detection / Jeffrey C. Jerman, Jason Brown, and Magalie Rocheville -- Novartis evaluation of the ForteBio Octet RED : a versatile instrument for direct-binding experiments / Eric Martin [and others] -- The pyramid approach to fragment-based biophysical screening / Glyn Williams -- Characterisation of antibodies against the active conformation of Gài1 using the SRU-BIND label free detection system / Melanie Leveridge, Chun-Wa Chung, and Trevor Wattam -- SPR based direct binding assays in drug discovery / Walter Huber -- Kinetic binding mechanisms: their contribution to an optimal therapeutic index / David C. Swinney -- ITC : more than just binding affinities / Ernesto Freire. 
504 |a Includes bibliographical references and index. 
520 |a Over the past two decades the benefits of label-free biosensor analysis have begun to make an impact in the market, and systems are beginning to be used as mainstream research tools in many drug discovery laboratories. Label-Free Technologies For Drug Discovery summarises the latest and emerging developments in label-free detection systems, their underlying technology principles and end-user case studies that reveal the power and limitations of label-free in all areas of drug discovery. Label-free technologies discussed include SPR, NMR, high-throughput mass spectrometry, resonant waveguide plat. 
588 0 |a Print version record. 
650 0 |a Drug development. 
650 1 2 |a Drug Discovery. 
650 2 2 |a Biosensing Techniques. 
650 2 2 |a Drug Design. 
650 4 |a Medicine. 
650 4 |a Pharmacy. 
650 7 |a MEDICAL  |x Drug Guides.  |2 bisacsh 
650 7 |a MEDICAL  |x Nursing  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacy.  |2 bisacsh 
650 7 |a Drug development.  |2 fast  |0 (OCoLC)fst00898670 
655 4 |a Electronic books. 
700 1 |a Cooper, M. A.  |q (Matthew A.) 
700 1 |a Mayr, Lorenz. 
776 0 8 |i Print version:  |t Label-free technologies for drug discovery.  |d Chichester, West Sussex, U.K. : John Wiley & Sons, 2011  |z 9780470746837  |w (DLC) 2010042191  |w (OCoLC)669122339 
856 4 0 |u https://doi.org/10.1002/9780470979129  |z Full Text via HEAL-Link 
994 |a 92  |b DG1